A longitudinal study tracking memory function in lymphoma patients found that older adults recovered memory after CAR T-cell therapy while younger patients showed unexpected cognitive vulnerability. The findings raise the likelihood that age-related baseline neurocognitive reserve and immune effects could shape post-therapy cognitive outcomes.